Celal Bayar University School of Medicine, Department of Obstetrics and Gynecology, Manisa, Turkey.
Gynecol Oncol. 2013 Dec;131(3):546-50. doi: 10.1016/j.ygyno.2013.08.038. Epub 2013 Sep 7.
The objectives of this study were to examine demographic and clinicopathologic characteristics and to determine the effects of primary surgery, surgical staging and the extensiveness of staging.
In a retrospective Turkish multicenter study, 539 patients, from 14 institutions, with borderline ovarian tumors were investigated. Some of the demographic, clinical and surgical characteristics of the cases were evaluated. The effects of type of surgery, surgical staging; complete or incomplete staging on survival rates were calculated by using Kaplan-Meier method.
The median age at diagnosis was 40 years (range 15-84) and 71.1% of patients were premenopausal. The most common histologic types were serous and mucinous. Majority of the staged cases were in Stage IA (73.5%). 242 patients underwent conservative surgery. Recurrence rates were significantly higher in conservative surgery group (8.3% vs. 3%). Of all patients in this study, 294 (54.5%) have undergone surgical staging procedures. Of the patients who underwent surgical staging, 228 (77.6%) had comprehensive staging including lymphadenectomy. Appendectomy was performed on 204 (37.8%) of the patients. The median follow-up time was 36 months (range 1-120 months). Five-year survival rate was 100% and median survival time was 120 months. Surgical staging, lymph node sampling or dissection and appendectomy didn't cause any difference on survival.
Comprehensive surgical staging, lymph node sampling or dissection and appendectomy are not beneficial in borderline ovarian tumors surgical management.
本研究的目的是探讨人口统计学和临床病理学特征,并确定初次手术、手术分期和分期范围的影响。
在一项回顾性的土耳其多中心研究中,对来自 14 家机构的 539 例交界性卵巢肿瘤患者进行了调查。评估了病例的一些人口统计学、临床和手术特征。采用 Kaplan-Meier 法计算不同手术类型、手术分期(完全分期与不完全分期)对生存率的影响。
诊断时的中位年龄为 40 岁(范围 15-84 岁),71.1%的患者为绝经前。最常见的组织学类型是浆液性和黏液性。大多数分期病例为 IA 期(73.5%)。242 例患者接受了保守性手术。保守性手术组的复发率明显较高(8.3%比 3%)。在本研究的所有患者中,有 294 例(54.5%)接受了手术分期。在接受手术分期的患者中,有 228 例(77.6%)进行了包括淋巴结切除术在内的全面分期。对 204 例(37.8%)患者进行了阑尾切除术。中位随访时间为 36 个月(范围 1-120 个月)。5 年生存率为 100%,中位生存时间为 120 个月。手术分期、淋巴结取样或切除术和阑尾切除术对生存没有任何影响。
全面的手术分期、淋巴结取样或切除术和阑尾切除术对交界性卵巢肿瘤的手术治疗没有益处。